Phathom Pharmaceuticals, Inc. (PHAT)

10.70 -1.08 (-9.13%) USD  |  NASDAQ  |  Apr 30, 12:04
More

Phathom Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for PHAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Replimune Group, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
MannKind Corp. Upgrade
Ocugen, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade